FDA Supplement Label Requirements: Required Brand Checklist

Compliant supplement formulas may still result in regulatory issues if label requirements are not met. FDA supplement label requirements mandate the disclosure of product identity, net quantity, Supplement Facts panel, ingredient declaration, responsible firm information, qualifying claims, and specific warnings when applicable.

Noncompliance with these requirements can lead to a product being misbranded, regardless of the safety or legality of its contents. Systematic label review mitigates compliance risk when structured in definable steps.

Refer to the following checklist prior to printing, product launch, submission to a retailer, or reformulation. The checklist details all required label elements, correct formatting for the Supplement Facts panel, criteria for allowable claims, and the role of testing in confirming label accuracy.

FDA Supplement Label Requirements: Definition and Scope

FDA supplement label requirements consist of federal regulations that govern the mandatory content and presentation of dietary supplement labels provided to consumers. These rules specify required panels, Supplement Facts formatting, ingredient disclosures, business identification, permissible claims, and issuance of warnings based on product composition and intended audience.

Requirements fall under the Dietary Supplement Health and Education Act of 1994 (DSHEA), which classifies supplements as a food category. FDA does not pre-approve dietary supplement labels prior to marketing. Brands remain responsible for accuracy and regulatory compliance.

Mandatory Dietary Supplement Label Elements

Dietary supplement labels must display product identity, net quantity, Supplement Facts panel, all ingredient information, responsible firm details, and any required directions or warnings. FDA’s Dietary Supplement Labeling Guide specifies five mandatory statements.

As outlined in the FDA labeling guide, these are: statement of identity, net quantity of contents, Supplement Facts panel, complete ingredient list, and the responsible firm’s name and address.

Statement of Identity

The label must state the product name and specify "dietary supplement" or a descriptive type, such as "herbal supplement." This statement is required on the principal display panel, which is typically the front-facing side visible to consumers.

Net Quantity of Contents

The package must clearly indicate the total amount of product by count, weight, volume, or an applicable measure. The stated quantity must match the actual content. Discrepancies, such as labeling "60 capsules" but containing only 58, constitute noncompliance.

Supplement Facts Panel

This boxed information area provides serving size, servings per container, dietary ingredients, amounts per serving, and Percent Daily Values where established by FDA.

Other Ingredients List

Non-dietary ingredients, including capsule materials, fillers, binders, flavors, colors, sweeteners, and preservatives, must be listed separately. These declarations adhere to general food ingredient labeling requirements.

Responsible Firm Information

The label must name and provide the address of the manufacturer, packer, or distributor. If the named firm does not manufacture the product, clarifying language such as "Manufactured for" or "Distributed by" should be used.

Formatting Requirements for the Supplement Facts Panel

The Supplement Facts panel must comply with FDA specifications for headings, serving details, ingredient nomenclature, amounts, units, Percent Daily Values, and required footnotes. Regulatory requirements are established in 21 CFR 101.36.

The "Supplement Facts" heading must outsize other text in the panel and extend the full width where feasible. Headings require bold font, information is enclosed within a box using hairlines, and the main type size must generally be no smaller than 8 point.

Serving Size and Servings per Container

Serving size reflects the recommended amount, expressed with accurate measurement terms (e.g., "tablets," "capsules," or "teaspoonfuls"). Serving size and directions must correspond precisely to the information in the panel.

Dietary Ingredient Names and Order

Ingredient names must adhere to FDA conventions. Botanicals must include the plant part, and all dietary ingredients should appear in the correct sequence according to regulatory guidance.

Amount per Serving

The measurable amount of each dietary ingredient must be declared using standardized units and must match both the formulation and substantiated claims.

Percent Daily Value

If FDA has established a Daily Value for an ingredient, labels must include the corresponding percentage. When no Daily Value exists, the ingredient and its amount must still be provided, but the Percent Daily Value is omitted.

Proprietary Blends

Proprietary blends may be listed under a defined heading, disclosing the blend’s total weight and listing ingredients in descending order by weight. Transparency and accurate representation are required for all claims, including those related to blends.

Permitted Claims on Supplement Labels

Supplement labels may include truthful, substantiated structure/function claims, nutrient content claims that comply with regulatory thresholds, and health claims that have received FDA authorization. Unauthorized disease claims are prohibited. Products marketed with such claims risk classification as unapproved drugs.

Structure/Function Claims

Structure/function claims describe the role of an ingredient in maintaining biological structure or function (e.g., "supports immune health"). These claims require substantiation and notification to FDA within 30 days of first marketing. Notification requirements are detailed here.

Nutrient Content Claims

Terms such as "high," "good source," or "free" are defined by FDA and may only be used when the product meets specific nutrient thresholds.

Health Claims

Authorized health claims describe scientifically substantiated relationships between substances and reduced risk of disease. FDA authorizes only certain health claims meeting defined evidentiary standards. Qualified health claims must include clarifying language that reflects the strength of supporting evidence.

Disease Claims

Statements suggesting the diagnosis, treatment, cure, or prevention of specific diseases (e.g., arthritis, diabetes, infection) are categorized as drug claims and are prohibited. Any such claims subject the product to risk of FDA enforcement as an unapproved drug.

Disclosure and Disclaimer for Structure/Function Claims

Structure/function claims must be accompanied by the following disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." The disclaimer must be in bold type at least as prominent as the claim text.

Required Warnings and Disclosures

Obligatory warnings and disclosures depend on product formula, intended audience, claim language, allergens, and safety considerations. Review each label in the context of its ingredients and user group.

Allergen Disclosures

In compliance with FALCPA, supplements containing any of the nine major food allergens—including sesame as of 2023—must identify these allergens on the label, either parenthetically after the ingredient or in a dedicated "Contains" statement.

Ingredient-Specific Cautions

Ingredients with known safety considerations, such as caffeine or certain botanicals, may require cautionary statements. Cautions must reflect the specific ingredients and up-to-date safety information.

Use-Specific Cautions

Products formulated for certain populations—such as adults, children, athletes, pregnant/nursing individuals, or those with medical conditions—must include relevant cautions based on ingredients and intended users.

Serious Adverse Event Reporting Contact

The label must provide a U.S. address or phone number for consumers to report serious adverse events, as mandated by law.

Systematic Label Review Prior to Product Launch

Brands ensure compliance by cross-referencing final artwork with FDA labeling requirements, the product formulation record, substantiation documents, and lab test results. Follow the subsequent evaluative steps in sequence.

Align Label Content With Master Formula

Verify each ingredient’s name, amount, blend composition, excipients, capsule materials, flavors, and allergens on the label using master formula records.

Confirm Consistency Among Serving Size and Use Directions

Serving size, recommended use directions, and servings per container must all consistently appear and correspond to claims regarding intake.

Validate Claims With Substantiation Files

All label claims must be accurate, substantiated, and avoid prohibited disease language. Documentation should support each claim’s accuracy.

Substantiate Label Information Through Lab Testing

Laboratory testing should confirm ingredient identity and amounts to support label representations, complementing but not replacing comprehensive legal review.

Examine Final Artwork Before Production

Review for correct spelling, units, formatting, panel placement, font size, presence of mandatory statements, and consistency across all product variants.

Common Supplement Labeling Errors

Frequent labeling errors include inaccurate Supplement Facts, unsupported or impermissible claims, missing contact information, incomplete ingredient declarations, and use of disease-claim language. A methodical review process reduces occurrence of these errors.

Improper Use of Drug-Like Terminology

Disease treatment, cure, prevention, or diagnostic language constitutes unapproved drug claims and represents a significant compliance risk.

Omission of Non-Active Ingredients

All required excipients, flavors, sweeteners, colors, preservatives, and processing aids must be disclosed to meet regulatory transparency standards.

Failure to Update Labels After Formula Changes

Labels must be revised to reflect changes in formulation, supplier, ingredient potency, or serving instructions.

Overlooking Individual Marketplace Requirements

Retailers and online platforms frequently impose additional requirements for testing, documentation, or restricted ingredients. Amazon, as an example, defines specific testing standards for supplement listings.

Testing and Certification in Label Compliance

Testing and third-party certification provide objective evidence to support key label claims and quality attributes but do not constitute FDA approval. These processes are conducted under standards such as those set by AOAC, USP, and FDA, and serve to reinforce, not supplant, legal compliance obligations.

Verification of Label Claims

Identity and potency testing for select ingredients substantiate declared label values. The BSCG Certified Quality program conducts ingredient identity and quantitative verifications aligned with recognized standards.

Ingredient Identity Review

Testing confirms the presence and accurate identification of labeled ingredients. While a label or spec sheet lists expected content, periodic analytical testing confirms actual content according to the label.

Banned Substance Screening for Products Marketed to Athletes

Brands targeting athletes may employ banned substance testing. The BSCG Certified Drug Free program screens for a comprehensive range of prohibited substances, prescription medications, over-the-counter drugs, and illicit compounds.

Limitations of Certification

Certification and laboratory testing serve as quality and risk management tools. Brands retain sole legal accountability for disclosure and compliance under FDA regulations.

Records Management for Label Compliance

Comprehensive records documenting formula development, label claims, ingredient sourcing, test results, and safety analyses expedite label review and support responses to regulatory inquiries.

Formula and Specification Documentation

Maintain master manufacturing records, ingredient specifications, and finished product specifications that link the label to the physical product.

Testing and Certificate Documentation

Retain certificates of analysis, laboratory test results, and internal review notes to support the validity of ingredient identification and stated label claims.

Claim Substantiation Documentation

Archive the scientific literature, justification for claim language, and documentation of the review and approval process for each claim.

Label Version Control

Track all versions of each label according to SKU, flavor, package size, market, approval date, and status to prevent obsolete or noncompliant versions from entering distribution.

Frequently Asked Questions

Does FDA Review Dietary Supplement Labels Before Market Entry?

No. FDA does not review or approve dietary supplement labels before products are marketed. The burden of compliance is on the manufacturer or distributor. FDA investigates only after the product is available if it is potentially misbranded or unsafe.

Are All Ingredients Required to Be Listed on Supplement Labels?

Yes. Both dietary and non-dietary ingredients must be declared. Placement varies: dietary ingredients appear in the Supplement Facts panel, non-dietary ingredients in a separate section.

What Does "FDA Registered" Mean on Supplement Labels?

Facility registration may apply, but "FDA registered" can be misleading if it implies official FDA product or label approval. Registration does not constitute certification, authorization, or endorsement of any specific supplement.

Are Internet Product Pages Subject to Labeling Rules?

Yes. Online product pages are regulated as labeling by FDA and as advertising by FTC. Both agencies enforce the same standards regarding permitted claims and representations.

When Should Brands Review a Supplement Label?

Brands should review labels before initial launch, after any formula or supplier modification, prior to market expansion, and whenever FDA or retailer requirements change. Consistent review ensures ongoing compliance.

Establishing and Maintaining Accurate Supplement Labels

Compliance with FDA requirements relies on verified product information, accurate Supplement Facts formatting, careful substantiation of claims, inclusion of obligatory warnings, and systematic documentation. An otherwise compliant product may be misbranded if any of these elements is missing or inaccurate.

The obligation for accurate and compliant labeling rests exclusively with the brand, as FDA does not engage in premarket label approval. Maintaining a structured, documented review process supports ongoing compliance.

Independent laboratory testing provides additional verification for label claims and ingredient identity. Programs such as BSCG supplement certification can assist with ingredient and label verification. However, no third-party program substitutes for comprehensive legal review and regulatory compliance.